Gibson Christopher

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
69
Insider Sells Sum
$36.9M

Insider Activity of Gibson Christopher

According to the SEC Form 4 filings, Gibson Christopher, being in a position of

  1. Chief Executive Officer at Recursion Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 883746 shares for $7.3M,
    over all time since 2021-12-07, has bought 0 shares, and sold 3991778 shares for $36.9M.

The largest sale of all time was on 2022-01-14 and amounted to 508000 shares of Recursion Pharmaceuticals, Inc. for $6.89M.

Biography of Gibson Christopher

No biography is available at this moment.

2024-10-03SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
20,000
0.006%
$6.08$121,600+0.83%
2024-10-02SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
20,000
0.0061%
$6.16$123,200-0.41%
2024-09-05SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
20,000
0.0072%
$6.14$122,800+6.48%
2024-09-04SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
20,000
0.0072%
$6.04$120,800+7.13%
2024-08-08SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
20,000
0.0075%
$6.50$130,000+0.3%
2024-08-07SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
30,000
0.0128%
$7.10$213,000+4.4%
2024-07-11SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
50,000
0.0185%
$7.47$373,5000%
2024-07-10SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
50,000
0.0186%
$7.48$374,0000%
2024-06-06SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
50,000
0.0217%
$9.00$450,000-19.2%
2024-06-05SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
50,000
0.0201%
$8.42$421,000-19.58%
2024-05-02SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
21,296
0.0089%
$8.47$180,377-7.29%
2024-05-01SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
50,000
0.0201%
$7.73$386,500-1.98%
2024-04-04SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
65,000
0.0311%
$9.02$586,300-6.99%
2024-04-03SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
65,000
0.0298%
$8.84$574,600-8.96%
2024-03-28SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
65,000
0.0305%
$10.10$656,500-17.85%
2024-03-06SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
61,319
0.0307%
$11.73$719,505-24.89%
2024-02-07SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
48,272
0.0209%
$9.22$444,981-4.71%
2024-01-03SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
55,853
0.0255%
$9.50$530,567-6.91%
2023-12-06SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
59,829
0.0291%
$7.49$448,394+22.1%
2023-11-01SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
62,177
0.0299%
$5.17$321,301+72.59%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.